Cofco Total Other Income Expense Net from 2010 to 2024

000930 Stock   5.92  0.06  1.02%   
Cofco Biochemical's Total Other Income Expense Net is increasing over the years with slightly volatile fluctuation. Total Other Income Expense Net is expected to dwindle to about -138.2 M. From 2010 to 2024 Cofco Biochemical Total Other Income Expense Net quarterly data regression line had arithmetic mean of (331,479,794) and significance of  0. View All Fundamentals
 
Total Other Income Expense Net  
First Reported
2010-12-31
Previous Quarter
-131.6 M
Current Value
-138.2 M
Quarterly Volatility
339.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cofco Biochemical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cofco Biochemical's main balance sheet or income statement drivers, such as Interest Expense of 118.4 M, Selling General Administrative of 184.1 M or Total Revenue of 21.4 B, as well as many indicators such as . Cofco financial statements analysis is a perfect complement when working with Cofco Biochemical Valuation or Volatility modules.
  
This module can also supplement various Cofco Biochemical Technical models . Check out the analysis of Cofco Biochemical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Cofco Stock

Cofco Biochemical financial ratios help investors to determine whether Cofco Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cofco with respect to the benefits of owning Cofco Biochemical security.